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Abstract
Background: The aim of this study was to assess attendance at the universal screening programme for thyroid function in pregnancy and 
attempt to evaluate the influence of age, number of past pregnancies, level of education, and place of residence on the attendance. The 
study was performed by means of a questionnaire. 
Material and methods: Our study was performed on the basis of an anonymous questionnaire handed out to 543 women aged 
16–45 years, on the third day of their puerperal stay in one of five obstetric wards in southern Poland. The questionnaire contained 
questions about participation in plasma level measurements of TSH, fT4, total T4, thyroid antibodies or thyroid ultrasound scanning 
at least once in pregnancy.
Results: The rate of attendance at any examination of thyroid function among pregnant women was 26.7%. The highest attendance rate 
(32.7%) was found among women living in provincial capitals or with higher education (41.3%), whereas the lowest was among women 
who had completed only primary school (11%) and those living in county towns (15%). The number of previous pregnancies did not influ-
ence the thyroid screening attendance. Women over 21 years of age participated in this screening programme more frequently (27.1–30%).
Conclusion: Less than one third of pregnant women participated in the thyroid function screening. Place of living, education level, and 
age were the main factors influencing the attendance rate. (Pol J Endocrinol 2011; 62 (5): 416–420)
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Streszczenie
Wstęp: Celem pracy było oszacowanie metodą ankietową odsetka ciężarnych, które wykonały w ciąży badania umożliwiające wykrycie 
zaburzeń funkcji tarczycy oraz próba oceny wpływu takich czynników, jak wiek, liczba ciąż, wykształcenie i miejsce zamieszkania na 
zgłaszalność do tych badań. 
Materiał i metody: Analizę przeprowadzono na podstawie anonimowych badań ankietowych, które przeprowadzono u 543 kobiet w wie-
ku 16–45 lat, w 3. dniu połogu w 5 oddziałach położniczych na terenie województwa małopolskiego i podkarpackiego. Pytania ankiety 
dotyczyły wykonania oznaczenia TSH, fT4, T4 całkowitej, przeciwciał przeciw tarczycowych oraz USG tarczycy przynajmniej 1 raz w ciąży.
Wyniki: Spośród ankietowanych 26,7% ciężarnych wykonało jakiekolwiek badanie oceniające funkcję tarczycy w ciąży. Najwięcej ciężar-
nych, które wykonały takie badanie, zamieszkiwało w mieście wojewódzkim (32,7%), a najmniej w mieście powiatowym (15%). Grupa 
ciężarnych z wykształceniem wyższym najczęściej (41,3%), a z wykształceniem podstawowym najrzadziej (11%) wykonywała takie badania. 
Nie stwierdzono istotnych statystycznie różnic w częstości wykonywania badania funkcji tarczycy pomiędzy grupami ciężarnych z innymi 
rodzajami wykształcenia. Częstość wykonywania tego badania nie różniła się pomiędzy grupą kobiet będących po raz pierwszy w ciąży 
a kobietami, które co najmniej raz urodziły. Częściej badanie funkcji tarczycy wykonywały pacjentki w wieku powyżej 21 lat (26,3–30%).
Wniosek: Mniej niż 1/3 ciężarnych wykonała badanie przesiewowe funkcji tarczycy. Wiek, miejsce zamieszkania i wykształcenie wpływały 
na zgłaszalność do badań przesiewowych funkcji tarczycy. (Endokrynol Pol 2011; 62 (5): 416–420)
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Introduction
Thyroid gland disorders commonly affect women of 
reproductive age [1]. Pathological processes invol-
ving the thyroid gland develop mainly as a result of 
inadequate iodine supplementation or autoimmune 
diseases. Autoimmune diseases of the thyroid gland are 
5- to 10-fold more frequent in women of reproductive 
age than in men [1]. These diseases attack 4% of women 
of reproductive age and 15% of them express antithy-
roid autoantibodies in blood [1]. Autoimmune thyroid 
diseases increase the risk of spontaneous miscarriage by 
up to four times [2]. Early miscarriages were observed 
in half of the women with positive antithyroid antibo-
dies [3, 4]. Research over the last decade has produced 
a significant body of evidence demonstrating changes 
in thyroid hormones blood levels in uncomplicated 
pregnancy. In the first trimester, the free fraction of 
serum thyroid hormones increases, whereas the TSH 
level is reduced [5]. While the pregnancy is progressing, 
the serum concentrations of thyroid hormones decline 
and the level of TSH grows [6–8]. Furthermore, in the 
third trimester of pregnancy, the expression of thyroid 
hormones receptors is decreased [9].
An increased level of TSH can be observed in about 
2.5% of pregnant women. According to some authors 
[10, 11], 1.5–2% of pregnant women are affected by 
clinically evident hypothyroidism. Untreated hyperthy-
roidism in pregnancy is associated with a doubled or 
even tripled risk of several complications: pregnancy-in-
duced hypertension, abruption of the placenta, preterm 
delivery, puerperal haemorrhage, or intrauterine death 
[10, 11]. This risk correlates with elevated TSH concen-
tration rather than with low level of thyroid hormones 
or an autoimmune thyroid disease [12, 13]. 
Hyperthyroidism occurs in 0.1–0.4% of pregnancies 
and Graves’ disease accounts for 85% of the cases. Un-
treated hyperthyroidism in pregnancy bears the risk of 
preeclampsia, preterm delivery, foetal hypotrophy, or 
even intrauterine death [14].
The aim of this study was to evaluate the proportion 
of pregnant women who were screened for possible 
thyroid dysfunction. Moreover, we tried to assess how 
the age, number of past pregnancies, level of education, 
and place of residence affected the rate of response to 
the screening programme. The research method applied 
was a survey questionnaire.
Material and methods
The analysis was based on data collected through 
an anonymous survey of 543 women aged 16 to 45 years, 
on their third day of puerperium, in five obstetric wards 
in the Małopolska and Podkarpacie provinces of Poland 
(Kraków, Krosno, Mysłowice, Chrzanów, Sucha Beskidz-
ka). The questionnaire included 18 questions regarding 
basic information about the respondents and multiple 
choice questions related to the topic (see: questionnaire). 
The questionnaires, to be filled in individually and in-
dependently by each respondent, were distributed and 
collected by midwives employed in these hospitals. The 
midwives could explain the questions that were unclear, 
but did not participate in the survey. The completed 
questionnaires were collected and returned to the re-
searchers for analysis. The respondents were divided 
into four groups according to their age. The first group 
comprised women aged under 21 years (11.8%); 48.3% of 
respondents were aged between 22 and 29; 31.7% of them 
30–37; and 8.2% — 38–45 years. The women were divided 
into groups by their (self-declared) level of education: 
university degree or equivalent 31.6%, post secondary 
vocational 10.9%, high school 37.6%, lower vocational 
11.4%, and primary school 8.5%. Concerning the place of 
living, the respondents were divided into the following 
groups: 32.1% lived in the provincial capital, 20.8% in 
a county town, 18.2% in a municipal town, while 28.9% 
were in a rural area. According to the number of previous 
pregnancies, the women were divided into primigravidae 
(49.7%) and multiparae (50.3%). The results were analysed 
statistically with the use of non-parametric tests. P values 
less than 0.05 were considered as significant.
Results
Thyroid function was evaluated in 145 pregnant 
women, which constitutes 26.7% of the population 
intended to be included in this study (Table I). Most of 
these women lived in the provincial capital (Table II) or 
completed higher education. We did not observe any 
statistically significant differences in the proportion 
of women screened for thyroid function between the 
remaining educational groups (Table III). There was no 
difference between women pregnant for the first time 
and those with previous pregnancies (Table IV). Women 
over the age of 21 years attended thyroid screening 
more frequently (Table V).
Discussion
The recommendations of the Polish Gynaecological 
Society, published in 2005, for the management of un-
complicated pregnancy do not address evaluation of the 
thyroid gland function [15]. Published in 2007, interna-
tional recommendations also do not advocate screening 
for TSH serum concentration in pregnant women [16]. 
However, Negro et al. found that in 115 subjects out of 
984 pregnant euthyroid women, thyroid peroxidase an-
tibodies were present [17]. Half of the total of anti-TPO 
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Table I. Number of pregnant patients who attended the thyroid function screening tests
Tabela I. Liczba kobiet, które zgłosiły się do badania przesiewowego funkcji tarczycy
Tested Not-tested
Number of women % Number of women %
Thyroid function screening 
tests in pregnancy
145 26.7 398 73.3
Table II. Place of residence of pregnant patients who attended the thyroid function screening tests
Tabela II. Miejsce zamieszkania kobiet a zgłaszalność do przesiewowych badań funkcji tarczycy
Attendance P
A B C D
Place of residence Provincial capital County town Municipal town Rural area 
Total number 
of women n = 174 n = 113 n = 99 n = 157
% Number of women %
Number 
of women %
Number 
of women %
Number 
of women
Thyroid function 
screening tests in 
pregnancy
32.7 55 15 17 26.3 28 25 43 < 0.05; A/C; A/D; C/D NS
Table III. Level of education of pregnant patients who attended the thyroid function screening tests
Tabela III. Wykształcenie kobiet ciężarnych a zgłaszalność do przesiewowych badań funkcji tarczcycy
Attendance P
A B C D E
Total number 
of women n = 172 n = 59 n = 204 n = 62 n = 46
Level 
of education
University degree 
or equivalent
Post secondary 
vocational
High 
school
Lower 
vocational
Primary 
school
% Number % Number % Number % Number % Number
Thyroid function 
screening tests in 
pregnancy
41.3 69 25.4 13 23.5 46 16 10 11 5
< 0.05; B/C; 
B/D; B/E; C/D; 
C/E; D/E NS
Table IV. Parity of pregnant patients who attended the thyroid function screening tests
Tabela IV. Dzietność kobiet ciężarnych zgłaszających się do badań przesiewowych funkcji tarczycy
Attendance P
Group of women Primigravidae (n = 270) Multiparae (n = 273)
W% Number W% Number
Thyroid function screening 
tests in pregnancy 26.3 71 26.4 72 NS
positive women were supplemented with levothyroxine 
and in this group miscarriages or premature births were 
less frequent than in the untreated controls [17]. In 2010, 
Negro et al. performed an analysis of obstetric outcomes 
and found no advantage in universal screening com-
pared to case finding only in women with a family history 
of thyroid disease risk factors [18]. Also in 2010, the same 
authors observed an increased incidence of pregnancy 
loss in women with blood TSH levels over 2.5 mIU/L 
[19]. Horacek et al. studied a population of 400 pregnant 
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Czech women, who were similar to Polish subjects and 
demonstrated the presence of thyroid disorders in 16.3% 
of cases by means of biochemical tests. They also found 
that examination of the thyroid function only in women 
with suspected thyroid disease on the basis of personal 
and/or family history or previous miscarriages was the 
cause of omission of about 50% of cases that required 
specialist treatment [20]. Vaidya et al. performed an analo-
gous analysis using criteria similar to those of Horacek et 
al. and found that an analysis of patient history, without 
universal screening, could result in the omission of about 
30% of cases of thyroid disorders that required therapy 
[21]. Thung et al. assessed the costs of routine screen-
ing for thyroid function in pregnancy and showed that 
the costs of tests and treatment are lower than those 
of treatment of neuropsychological impairment in off-
spring of untreated mothers with undiagnosed thyroid 
conditions [22]. Glinoer and Spencer stated that there is 
an urgent need for universal screening for serum TSH 
in pregnancy [23]. 
In our survey, less than one third of pregnant women 
from the Małopolska province were tested one way or 
another for their thyroid function. Factors influencing 
the frequency of attendance were age, place of living, 
and level of education. The same factors determined 
the frequency of attendance for the screening test for 
glucose metabolism [24]. 
Taking into account the geographical location of this 
region of Poland, it would be advantageous to screen 
pregnant women for serum TSH level on a routine basis.
Conclusion
Less than one third of women were tested for thyroid 
function. The frequency of attendance was mainly in-
fluenced by age, place of living, and level of education. 
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QUESTIONNAIRE
The following questionnaire is anonymous and intended for research purposes only. 
1. What is your age?
2. What is your place of residence?
a) Provincial capital
b) County town
c) Municipal town
d) Rural area
3. What is your level of education?
a) Primary school
b) High school 
c) Secondary vocational
d) Bachelor’s degree
e) Master’s degree
f) Post secondary vocational
g) Lower vocational
4. Do you have any chronic diseases?
a) Diabetes
b) Hypertension
c) Hypo- or hyperthyroidism (please underline)
d) Other thyroid disorders (please specify) ................................
e) Other diseases (please specify) ............................................
..............................................................................................
..............................................................................................
5. Is the last pregnancy your:
a) First
b) Subsequent (please specify which one) ................................
6. The previous pregnancy ended in:
a) Miscarriage
b) Preterm delivery 
c) Timely delivery (37–40 week)
d) Postterm delivery
7. The previous uncomplicated pregnancies ended in:
a) Vaginal birth
b) Caesarean section
Example: 1st pregnancy, vaginal delivery
 2nd pregnancy, caesarean section
8. Children born previously:
a) Are healthy
b) Were born with a congenital abnormality
c) Are suffering from cerebral palsy secondary to perinatal 
complications 
d) Had other problems (please describe) ...................................
..............................................................................................
9. Did your last pregnancy progress normally?
a) Yes
b) No
10. If NOT, please specify what happened (please tick all 
symptoms you had and specify when did they start 
appearing)
a) Vaginal bleeding
b) Premature uterine contractions
c) Premature rupture of membranes
d) Oedemas
e) Elevated blood pressure
f) Proteinuria
g) Vomiting
h) Anaemia
i) Others — please specify .......................................................
..............................................................................................
11. How much weight did you gain during your last pregnancy?
a) Less than 10 kg
b) 10–15 kg
c) More than 15 kg
12. In which week of the last pregnancy was your child born?
..............................................................................................
13. The last pregnancy ended in:
a) Vaginal birth
b) Caesarean section
14. Your youngest child:
a) Is healthy 
b) Was born with a congenital abnormality 
c) Was born with cerebral palsy
d) Has other problems (please describe) ...................................
..............................................................................................
15. What were your youngest child’s Apgar scores and birth 
weight?
Apgar scores .........................................................................
Birth weight ..........................................................................
16. Have you had any thyroid function tests in the last 
pregnancy (by taking your blood sample and determination 
of thyroid hormones: TSH, fT4, fT3)?
a) Yes
b) No
17. Have you had any thyroid tests in the last pregnancy (by 
taking your blood sample and determination of antithyroid 
antibodies: anti-TPO, anti-TG)? 
a) Yes
b) No
18. Have you had thyroid sonography examinations in the last 
pregnancy (a hand-held probe of the sonographic scanner 
is placed directly on the neck for a few minutes and the 
patient is given a printed description of the result)?
a) Yes
b) No
